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a b s t r a c t
The placenta and tumors share important characteristics, including a requirement to establish effective
angiogenesis. In the case of the placenta, optimal angiogenesis is required to sustain the blood ﬂow
required to maintain a successful pregnancy, whereas in tumors establishing new blood supplies is
considered a key step in supporting metastases. Therefore the development of novel angiogenesis in-
hibitors has been an area of active research in oncology. A subset of the molecular processes regulating
angiogenesis are well understood in the context of both early placentation and tumorigenesis. In this
review we focus on the well-established role of androgen regulation of angiogenesis in cancer and relate
these mechanisms to placental angiogenesis. The physiological actions of androgens are mediated by the
androgen receptor (AR), a ligand dependent transcription factor. Androgens and the AR are essential for
normal male embryonic development, puberty and lifelong health. Defects in androgen signalling are
associated with a diverse range of clinical disorders in men and women including disorders of sex
development (DSD), polycystic ovary syndrome in women and many cancers. We summarize the diverse
molecular mechanisms of androgen regulation of angiogenesis and infer the potential signiﬁcance of
these pathways to normal and pathogenic placental function. Finally, we offer potential research ap-
plications of androgen-targeting molecules developed to treat cancer as investigative tools to help
further delineate the role of androgen signalling in placental function and maternal and offspring health
in animal models.
© 2017 Elsevier Ltd. All rights reserved.
1. Introduction
It has long been recognized that the placenta and tumors share
important characteristics. These include mechanisms related to
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